Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is -84.15% as of the fiscal period ended Wednesday, December 31, 2025.
Limited history available
CUPR Return on Invested Capital (ROIC) has fewer than three reported periods, so a trend chart would be misleading.
RETURN ON INVESTED CAPITAL (ROIC)
-84.15%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.62%
median of 547 covered companies
CURRENT VS SECTOR MEDIAN
-166.13%
vs the sector median at left
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Market Cap
$5.89M
Return on Invested Capital (ROIC)
-84.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.94M
Return on Invested Capital (ROIC)
-122.15%
TTM Avg
-90.24%
3Y Avg
-109.34%
5Y Avg
-347.01%
Market Cap
$5.98M
Return on Invested Capital (ROIC)
-82.84%
TTM Avg
-84.28%
3Y Avg
-109.54%
5Y Avg
-250.89%
Market Cap
$6.08M
Return on Invested Capital (ROIC)
-0.32%
TTM Avg
-32.77%
3Y Avg
-50.72%
5Y Avg
-41.90%
Market Cap
$6.13M
Return on Invested Capital (ROIC)
-209.05%
TTM Avg
-147.42%
3Y Avg
-107.09%
5Y Avg
-98.13%
Market Cap
$5.63M
Return on Invested Capital (ROIC)
-94.08%
TTM Avg
-1223.16%
3Y Avg
-731.00%
5Y Avg
-532.24%
Market Cap
$5.57M
Return on Invested Capital (ROIC)
-179.58%
TTM Avg
-259.96%
3Y Avg
-220.56%
5Y Avg
-170.22%
Market Cap
$6.21M
Return on Invested Capital (ROIC)
-117.93%
TTM Avg
-116.75%
3Y Avg
-95.39%
5Y Avg
-83.55%
Market Cap
$5.36M
Return on Invested Capital (ROIC)
-156.69%
TTM Avg
-654.50%
3Y Avg
-599.09%
5Y Avg
-420.09%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) | $5.89M | -84.15% | N/A | N/A | N/A |
| Lucyd, Inc (LUCY)vs › | $5.94M | -122.15% | -90.24% | -109.34% | -347.01% |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $5.98M | -82.84% | -84.28% | -109.54% | -250.89% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.08M | -0.32% | -32.77% | -50.72% | -41.90% |
| Femasys Inc. (FEMY)vs › | $6.13M | -209.05% | -147.42% | -107.09% | -98.13% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | -94.08% | -1223.16% | -731.00% | -532.24% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.57M | -179.58% | -259.96% | -220.56% | -170.22% |
| Biomerica, Inc. (BMRA)vs › | $6.21M | -117.93% | -116.75% | -95.39% | -83.55% |
| Alzamend Neuro Inc (ALZN)vs › | $5.36M | -156.69% | -654.50% | -599.09% | -420.09% |
| Lunai Bioworks Inc. (LNAI)vs › | $5.36M | N/A | -67.32% | -73.33% | -73.33% |
ROIC
-84.2%
ROE
-92.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | -84.15% |
